Insights

The Rise of Direct-to-Consumer Drug Pricing 

Learn More

Navion Update: Pfizer Announces Most Favored Nation (MFN) Drug Pricing in the U.S. 

Learn More

Q3 2025 FDA Drug Approvals: Wegovy, HIV PrEP, RSV Protection & More 

Learn More

Pharmacy Spend: Why Clinical Strategy Is the New Cost Strategy 

Learn More

Navion Launches Pharmacy Partner Portal to Empower Clients with Marketing, Education, and Growth Solutions 

Learn More

Why Regular Market Checks Are One of the Smartest Moves in Pharmacy Oversight 

Learn More

The Current State of ADHD Medications: Shortages, Safety Risks, and Solutions for Plan Sponsors 

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Clinical Insight

The Rise of Direct-to-Consumer Drug Pricing 

AlignRx is Now Navion